Possible exacerbation of myasthenia gravis by ciprofloxacin.

Suppr

超能文献

作者信息

Moore B, Safani M, Keesey J

出版信息

Lancet. 1988 Apr 16;1(8590):882. doi: 10.1016/s0140-6736(88)91627-3.

DOI:10.1016/s0140-6736(88)91627-3

PMID:2895386

Abstract

摘要

相似文献

Possible exacerbation of myasthenia gravis by ciprofloxacin.

Lancet. 1988 Apr 16;1(8590):882. doi: 10.1016/s0140-6736(88)91627-3.

[Exacerbation of myasthenia gravis by pefloxacin].

Rev Neurol (Paris). 1995 Apr;151(4):286-7.

[Fluoroquinolone associated myasthenia gravis exacerbation: clinical analysis of 9 cases].

Zhonghua Yi Xue Za Zhi. 2013 May 7;93(17):1283-6.

Comment: Myasthenia gravis and ciprofloxacin.

Ann Pharmacother. 1992 Feb;26(2):265. doi: 10.1177/106002809202600229.

Ciprofloxacin and myasthenia gravis.

BMJ. 1990 Oct 6;301(6755):818. doi: 10.1136/bmj.301.6755.818-a.

Myasthenia gravis and ciprofloxacin.

Acta Neurol Scand. 1996 Dec;94(6):419-20. doi: 10.1111/j.1600-0404.1996.tb00055.x.

Exacerbation of myasthenia gravis after tourniquet release.

J Clin Anesth. 2007 Nov;19(7):543-5. doi: 10.1016/j.jclinane.2007.01.011.

Myasthenia gravis with superimposed spinal cord injury: a case report.

J Rehabil Med. 2008 Aug;40(8):684-6. doi: 10.2340/16501977-0222.

[Electroglottographic studies in myasthenia gravis patients--swallowing in exacerbation and remission stage].

Rinsho Shinkeigaku. 1997 Sep;37(9):841-4.

Probable exacerbation of myasthenia gravis by ofloxacin.

J Neurol. 1993 Sep;240(8):508. doi: 10.1007/BF00874123.

引用本文的文献

Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.

J Clin Med. 2021 Apr 6;10(7):1537. doi: 10.3390/jcm10071537.

Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments.

Front Mol Neurosci. 2020 Aug 14;13:156. doi: 10.3389/fnmol.2020.00156. eCollection 2020.

Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Drug Saf. 2011 Oct 1;34(10):839-47. doi: 10.2165/11593110-000000000-00000.

Myasthenic crisis.

Neurocrit Care. 2005;3(3):189-94. doi: 10.1385/NCC:3:3:189.

Tolerability of fluoroquinolone antibiotics. Past, present and future.

Drug Saf. 1995 Dec;13(6):343-58. doi: 10.2165/00002018-199513060-00004.

Probable exacerbation of myasthenia gravis by ofloxacin.

J Neurol. 1993 Sep;240(8):508. doi: 10.1007/BF00874123.

Ciprofloxacin and myasthenia gravis.

BMJ. 1990 Oct 6;301(6755):818. doi: 10.1136/bmj.301.6755.818-a.

Clinical features and management of adverse effects of quinolone antibacterials.

Drug Saf. 1991 Jan-Feb;6(1):8-27. doi: 10.2165/00002018-199106010-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Possible exacerbation of myasthenia gravis by ciprofloxacin.

Lancet. 1988 Apr 16;1(8590):882. doi: 10.1016/s0140-6736(88)91627-3.

[Exacerbation of myasthenia gravis by pefloxacin].

Rev Neurol (Paris). 1995 Apr;151(4):286-7.

[Fluoroquinolone associated myasthenia gravis exacerbation: clinical analysis of 9 cases].

Zhonghua Yi Xue Za Zhi. 2013 May 7;93(17):1283-6.

Comment: Myasthenia gravis and ciprofloxacin.

Ann Pharmacother. 1992 Feb;26(2):265. doi: 10.1177/106002809202600229.

Ciprofloxacin and myasthenia gravis.

BMJ. 1990 Oct 6;301(6755):818. doi: 10.1136/bmj.301.6755.818-a.

Myasthenia gravis and ciprofloxacin.

Acta Neurol Scand. 1996 Dec;94(6):419-20. doi: 10.1111/j.1600-0404.1996.tb00055.x.

Exacerbation of myasthenia gravis after tourniquet release.

J Clin Anesth. 2007 Nov;19(7):543-5. doi: 10.1016/j.jclinane.2007.01.011.

Myasthenia gravis with superimposed spinal cord injury: a case report.

J Rehabil Med. 2008 Aug;40(8):684-6. doi: 10.2340/16501977-0222.

[Electroglottographic studies in myasthenia gravis patients--swallowing in exacerbation and remission stage].

Rinsho Shinkeigaku. 1997 Sep;37(9):841-4.

Probable exacerbation of myasthenia gravis by ofloxacin.

J Neurol. 1993 Sep;240(8):508. doi: 10.1007/BF00874123.

引用本文的文献

Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.

J Clin Med. 2021 Apr 6;10(7):1537. doi: 10.3390/jcm10071537.

Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments.

Front Mol Neurosci. 2020 Aug 14;13:156. doi: 10.3389/fnmol.2020.00156. eCollection 2020.

Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Drug Saf. 2011 Oct 1;34(10):839-47. doi: 10.2165/11593110-000000000-00000.

Myasthenic crisis.

Neurocrit Care. 2005;3(3):189-94. doi: 10.1385/NCC:3:3:189.

Tolerability of fluoroquinolone antibiotics. Past, present and future.

Drug Saf. 1995 Dec;13(6):343-58. doi: 10.2165/00002018-199513060-00004.

Probable exacerbation of myasthenia gravis by ofloxacin.

J Neurol. 1993 Sep;240(8):508. doi: 10.1007/BF00874123.

Ciprofloxacin and myasthenia gravis.

BMJ. 1990 Oct 6;301(6755):818. doi: 10.1136/bmj.301.6755.818-a.

Clinical features and management of adverse effects of quinolone antibacterials.

Drug Saf. 1991 Jan-Feb;6(1):8-27. doi: 10.2165/00002018-199106010-00002.